CUREBOUND INC

As filed

Subsection

03

NTEE code

G123

Classification

1000

Street

9605 SCRANTON RD STE 120

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2025

• CUREBOUND IS A COMMUNITY-POWERED CANCER RESEARCH ACCELERATOR WITH A UNIQUE FUNDING MODEL BUILT ON A CORE BELIEF THAT THE BEST IDEAS HAPPEN WHEN THE RIGHT PEOPLE WORK TOGETHER. WE UNITE TOP SCIENTISTS, PASSIONATE ADVOCATES, ENTREPRENEURS AND INVESTORS TO ADVANCE CANCER RESEARCH THAT HAS THE GREATEST OPPORTUNITY TO IMPROVE DETECTION, TREATMENT, AND SURVIVORSHIP. ALL CUREBOUND GRANTS DEMAND SCIENTIFIC COLLABORATION ACROSS INSTITUTIONS TO DRIVE RESULTS FOR PATIENTS WHO NEED IT NOW. THROUGH RIGOROUS REVIEW AND TRANSPARENCY, WE DIRECT EVERY INVESTMENT DOLLAR TOWARDS MEANINGFUL IMPACT. REPRESENTATIVE RESEARCH PARTNER INSTITUTIONS INCLUDE (BUT NOT LIMITED TO): UC SAN DIEGO MOORES CANCER CENTER, THE SALK INSTITUTE, SANFORD-BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, RADY CHILDREN'S HOSPITAL, SCRIPPS RESEARCH, AND LA JOLLA INSTITUTE OF IMMUNOLOGY.HEADQUARTERED IN SAN DIEGO, ONE OF THE NATION'S PREMIER HUBS FOR CANCER RESEARCH AND LIFE-SCIENCE INNOVATION, CUREBOUND CATALYZES COMPLEMENTARY STRENGTHS ACROSS BIOLOGY, TECHNOLOGY, DATA SCIENCE, AND CLINICAL NETWORKS TO ACCELERATE THE TRANSLATION OF DISCOVERY INTO CLINICAL IMPACT. CUREBOUND ALLOCATES AND ADMINISTERS RESEARCH FUNDING THROUGH FIVE GRANT MECHANISMS SPANNING DISCOVERY THROUGH CLINICAL TRANSLATION: DISCOVERY, TARGETED, CATALYST, EQUITY, CURE PRIZE. EACH OF THESE GRANT TYPES ALIGNS TO CUREBOUND'S OVERARCHING AND RESEARCH ROADMAP WITH CLEARLY DEFINED TIMELINES AND MEASURABLE MILESTONES THAT ARE TRACKED TO ACCELERATE PROGRESS.

  Expenses $11,714,338 · Grants $10,238,599

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2025

As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

The first 25 listed. Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2025

  Revenue

  $10,968,237

  Expenses

  $14,851,654

  Contributions

  $7,968,991

  Grants paid

  $10,238,599

• 2023

  Revenue

  $10,395,528

  Expenses

  $12,500,342

  Contributions

  $7,931,168

  Grants paid

  $8,400,965

• 2022

  Revenue

  $19,804,413

  Expenses

  $6,229,069

  Contributions

  $18,221,209

  Grants paid

  $2,998,145

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $8,784,431

  Expenses

  $2,833,605

  Assets (EOY)

  $7,606,274

• 2020 · 990

  Revenue

  $1,362,913

  Expenses

  $872,066

  Assets (EOY)

  $880,045

• 2019 · 990

  Revenue

  $4,556,994

  Expenses

  $4,625,584

  Assets (EOY)

  $3,473,294

• 2018 · 990

  Revenue

  $4,421,873

  Expenses

  $4,370,723

  Assets (EOY)

  $3,363,996

• 2017 · 990

  Revenue

  $3,679,754

  Expenses

  $3,704,799

  Assets (EOY)

  $2,805,160

• 2016 · 990

  Revenue

  $3,188,206

  Expenses

  $3,276,224

  Assets (EOY)

  $2,448,150

• 2015 · 990

  Revenue

  $2,794,005

  Expenses

  $2,728,021

  Assets (EOY)

  $1,704,820

• 2014 · 990

  Revenue

  $1,957,467

  Expenses

  $2,413,737

  Assets (EOY)

  $1,249,681

• 2013 · 990

  Revenue

  $2,373,680

  Expenses

  $1,772,697

  Assets (EOY)

  $1,120,857

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.

Grants made

• THE REGENTS OF UNIVERSITY OF CALIFORNIA UC SAN DIEGO

  $5,743,423

  2025 · SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

• The Regents of University of California

  $3,340,462

  2023 · Support Cancer Research

• SANFORD BURNHAM PREBYS

  $1,529,548

  2025 · SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

• UCSD Foundation

  $1,347,134

  2022 · Support Cancer Research

• THE SALK INSTITUTE FOR BIOLOGICAL STUDIES

  $849,414

  2025 · SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

• La Jolla Institute for Immunology

  $603,832

  2023 · Support Cancer Research

• SCRIPPS RESEARCH

  $537,267

  2025 · SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

• La Jolla Institute for Immunology

  $464,486

  2022 · Support Cancer Research

• Sanford Burnham Presbys Medical

  $400,000

  2022 · Support Cancer Research

• Salk Institute for Biological Studies

  $385,950

  2022 · Support Cancer Research

The 10 largest by cash amount. The API serves every itemized grant.

Where these grants went next →

Grants received

• FIDELITY INVESTMENTS CHARITABLE GIFT FUND

  $612,890

  2024 · For grant recipient's exempt purposes

• DONOR ADVISED CHARITABLE GIVING

  $606,434

  2022 · HEALTH

• DONOR ADVISED CHARITABLE GIVING

  $500,427

  2024 · HEALTH

• FIDELITY INVESTMENTS CHARITABLE GIFT FUND

  $484,481

  2023 · For grant recipient's exempt purposes

• JEWISH COMMUNITY FOUNDATION OF SAN DIEGO

  $473,416

  2024 · GENERAL

• NATIONAL PHILANTHROPIC TR

  $398,550

  2024 · PUBLIC, SOCIETAL BENEFIT

• JEWISH COMMUNITY FOUNDATION OF SAN DIEGO

  $385,981

  2022 · GENERAL

• JEWISH COMMUNITY FOUNDATION OF SAN DIEGO

  $380,880

  2023 · GENERAL

• DONOR ADVISED CHARITABLE GIVING

  $309,550

  2023 · HEALTH

• NATIONAL PHILANTHROPIC TR

  $253,500

  2023 · PUBLIC, SOCIETAL BENEFIT

The 10 largest by cash amount. The API serves every itemized grant.

Other IRS files